clinical trials

Forty Seven and AstraZenca Team up on NHL Triple-Combination Therapy
Forty Seven and AstraZenca Team up on NHL Triple-Combination Therapy
BioSpace
AstraZeneca
Forty Seven
clinical trials
diffuse large B-cell lymphoma
Flag link:
Moderna Publishes Influenza Vaccine Clinical Trial Data
Moderna Publishes Influenza Vaccine Clinical Trial Data
BioSpace
Moderna Therapeutics
clinical trials
vaccines
MRNA
H10N8
H7N0
Flag link:
Xencor begins phase 1 trial of XmAb23104 in advanced solid tumors
Xencor begins phase 1 trial of XmAb23104 in advanced solid tumors
Pharmaceutical Business Review
Xencor
solid tumors
bispecific antibodies
clinical trials
XmAb23104
Flag link:
Magenta Therapeutics presents updated Phase 2 clinical data on MGTA-456 cell therapy
Magenta Therapeutics presents updated Phase 2 clinical data on MGTA-456 cell therapy
Pharmaceutical Business Review
Magenta Therapeutics
cell therapy
clinical trials
MGTA-456
inherited metabolic disorders
metabolic disorders
Flag link:
Experimental Drug For Huntington's Disease Jams Malfunctioning Gene
Experimental Drug For Huntington's Disease Jams Malfunctioning Gene
NPR
Huntington's disease
RG6042
clinical trials
Roche
Genentech
Flag link:
Oramed spearheading human oral insulin trials in 37 US centers
Oramed spearheading human oral insulin trials in 37 US centers
CP Wire
Oramed
insulin
oral insulin
diabetes
type 2 diabetes
clinical trials
Flag link:
Oramed spearheading human oral insulin trials in 37 US centers
Oramed
insulin
type 2 diabetes
diabetes
clinical trials
oral insulin
Flag link:
Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials
Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials
Xconomy
IPOs
clinical trials
Axcella Health
Cortexzyme
Milestone Pharmaceuticals
NextCure
Trevi Therapeutics
Flag link:
Once the center of a public storm of anger over denied drug, Chimerix now can’t even recruit patients for their trials
Once the center of a public storm of anger over denied drug, Chimerix now can’t even recruit patients for their trials
Endpoints
Chimerix
patients
clinical trials
Brincidofovir
Flag link:
Bristol-Myers' Opdivo fails late-stage brain cancer trial
Bristol-Myers' Opdivo fails late-stage brain cancer trial
Yahoo/Reuters
Bristol-Myers Squibb
Opdivo
clinical trials
glioblastoma multiforme
Flag link:
Eli Lilly's Emgality shows positive Phase 3 results in treatment of migraine
Eli Lilly's Emgality shows positive Phase 3 results in treatment of migraine
Pharmafile
Eli Lilly
migraines
clinical trials
Emgality
Flag link:
Watch out AbbVie and J&J, AstraZeneca just took another big swing at one of your star cancer drug franchises
Watch out AbbVie and J&J, AstraZeneca just took another big swing at one of your star cancer drug franchises
Endpoints
AstraZeneca
Calquence
clinical trials
chronic lymphocytic leukemia
AbbVie
JNJ
Imbruvica
Flag link:
Tencent Starts Collecting Medical Data On U.K. Patients In Parkinson's Trial
Tencent Starts Collecting Medical Data On U.K. Patients In Parkinson's Trial
Forbes
Tencent
clinical trials
Parkinson's Disease
Medopad
artificial intelligence
Flag link:
GW Pharma scores another PhIII win for its cannabinoid in rare form of epilepsy
GW Pharma scores another PhIII win for its cannabinoid in rare form of epilepsy
Endpoints
GW Pharma
clinical trials
Epidiolex
cannabindoids
tuberous sclerosis complex
Flag link:
FDA Raises Concerns With Novartis in Clinical Inspection
FDA Raises Concerns With Novartis in Clinical Inspection
RAPS.org
Novartis
FDA
Mayzent
siponimod
clinical trials
multiple sclerosis
Flag link:
Neurocrine’s Opicapone Plus Levodopa Improves Parkinson’s Symptoms
Neurocrine’s Opicapone Plus Levodopa Improves Parkinson’s Symptoms
BioSpace
Neurocrine Biosciences
clinical trials
opicapone
Parkinson's Disease
Flag link:
Cytokinetics' comeback attempt with second-gen drug is slammed by a PhII failure in ALS
Cytokinetics' comeback attempt with second-gen drug is slammed by a PhII failure in ALS
Endpoints
Cytokinetics
clinical trials
reldesemtiv
ALS
Flag link:
Exelixis initiates phase 3 trial of cabozantinib in advanced renal cell carcinoma
Exelixis initiates phase 3 trial of cabozantinib in advanced renal cell carcinoma
Pharmaceutical Business Review
Exelixis
clinical trials
cabozantinib
Cabometyx
advanced renal cell carcinoma
Flag link:
Rose-tinted glasses might not save Genkyotex
Rose-tinted glasses might not save Genkyotex
EP Vantage
Genkyotex
primary biliary cholangitis
GKT831
clinical trials
Flag link:
Caris aims to bridge gap between patients, precision trials with Pharmatech takeout
Caris aims to bridge gap between patients, precision trials with Pharmatech takeout
BioCentury
Caris
Pharmatech
molecular profiling
drug development
precision medicine
clinical trials
cancer
Flag link:

Pages